Supplemental material
Open access
2,757
Views
0
CrossRef citations to date
0
Altmetric
Commentary and Views
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
Aimee E. MatteiEpiVax, Inc, Providence, RI, USACorrespondence[email protected]
View further author information
, View further author information
Andres H. GutierrezEpiVax, Inc, Providence, RI, USAView further author information
, Soorya SeshadriEpiVax, Inc, Providence, RI, USAView further author information
, Jacob TivinEpiVax, Inc, Providence, RI, USAView further author information
, Matt ArditoEpiVax, Inc, Providence, RI, USAView further author information
, Amy S. RosenbergEpiVax, Inc, Providence, RI, USAView further author information
, William D. MartinEpiVax, Inc, Providence, RI, USAView further author information
& Anne S. De GrootEpiVax, Inc, Providence, RI, USACorrespondence[email protected]
View further author information
show allView further author information
Article: 2333729
|
Received 04 Jan 2024, Accepted 19 Mar 2024, Published online: 27 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.